3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
7
Sarcoma
6
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
3
Liposarcoma, Myxoid
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Melanoma
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Advanced Refractory Solid Tumors
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Small Cell Lung Cancer Limited Stage
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Myosarcoma
1
Lymphatic Metastasis
1
Lymphangiosarcoma
1
Locally Recurrent Rectal Cancer
1
Interventions
Etoposide
2
toripalimab
1
apatinib
1
Radiation Dose Hypofractionation
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Small Cell Lung Cancer Limited Stage
×
Radiation Dose Hypofractionation
×
Clear all
NCT04543890
2020-09-10
CTV
Zhejiang Cancer Hospital
Phase 2
Unknown
300 enrolled